What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Kairbaan Hodivala-Dilke mainly investigates Cell biology, Integrin, Pathology, Angiogenesis and Neovascularization.
His Cell biology research is multidisciplinary, incorporating perspectives in Ex vivo, Endocrinology, Internal medicine, Endothelium and Vascular endothelial growth factor A.
His studies in Integrin integrate themes in fields like Fibronectin, Focal adhesion and Keratinocyte.
The study incorporates disciplines such as Integrin alphaVbeta3, Cancer and Pericyte in addition to Pathology.
His biological study spans a wide range of topics, including Endothelial stem cell, Mural cell and Signal transduction.
Kairbaan Hodivala-Dilke combines subjects such as Hemostasis and Cre recombinase, Genetically modified mouse with his study of Neovascularization.
His most cited work include:
- β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival (673 citations)
- Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts (598 citations)
- Bone marrow contributes to renal parenchymal turnover and regeneration (587 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Angiogenesis, Cancer research, Cell biology, Integrin and Neovascularization.
His Angiogenesis study incorporates themes from Endothelial stem cell, Ex vivo, Immunology, Pathology and Vascular endothelial growth factor A.
His research in the fields of Bone marrow and Stroma overlaps with other disciplines such as Population.
His research integrates issues of Cancer, Metastasis and Function in his study of Cancer research.
He usually deals with Cell biology and limits it to topics linked to Internal medicine and Oncology.
Beta is closely connected to Alpha in his research, which is encompassed under the umbrella topic of Integrin.
He most often published in these fields:
- Angiogenesis (44.68%)
- Cancer research (37.59%)
- Cell biology (37.59%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (37.59%)
- Angiogenesis (44.68%)
- Integrin (31.91%)
In recent papers he was focusing on the following fields of study:
Kairbaan Hodivala-Dilke spends much of his time researching Cancer research, Angiogenesis, Integrin, Endothelial stem cell and Metastasis.
His Cancer research study integrates concerns from other disciplines, such as Blood vessel, Tyrosine kinase and Phosphorylation, Focal adhesion.
His Angiogenesis research is multidisciplinary, relying on both Heart disease, Cilengitide and Cell biology.
His work on PI3K/AKT/mTOR pathway as part of general Cell biology study is frequently linked to Dual role, therefore connecting diverse disciplines of science.
His Integrin research is multidisciplinary, incorporating elements of Alpha, Antagonist, Beta, Conformational change and Peptide.
His Endothelial stem cell research focuses on Cancer and how it relates to Doxorubicin, Integrin alphaVbeta3 and Chemotherapy.
Between 2015 and 2021, his most popular works were:
- Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment. (50 citations)
- αvβ3 Integrin and tumour blood vessels-learning from the past to shape the future. (47 citations)
- Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction (41 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Kairbaan Hodivala-Dilke mostly deals with Angiogenesis, Cancer research, Neovascularization, Stromal cell and Endothelial stem cell.
His Angiogenesis study combines topics in areas such as Cell biology, Proto-oncogene tyrosine-protein kinase Src, Phosphorylation, Focal adhesion and Integrin.
His Cell biology research incorporates elements of Phenotype and Pericyte.
Kairbaan Hodivala-Dilke is studying Integrin alphaVbeta3, which is a component of Integrin.
His work deals with themes such as Transcriptome and Endothelium, which intersect with Cancer research.
In Endothelial stem cell, Kairbaan Hodivala-Dilke works on issues like Immunology, which are connected to Blood vessel, Tyrosine kinase and Paracrine signalling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
